BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• BioMidwest

  Veniti Announces First U.S. Patients Enrolled In VIRTUS Trial

  December 1, 2014

   · 

  2 min read
• Policy

  Regeneron Release: EYLEA (aflibercept) Injection Accepted For Priority Review By FDA For Diabetic Retinopathy In Patients With Diabetic Macular Edema

  December 1, 2014

   · 

  9 min read
• Drug Development

  Karyopharm Therapeutics Announces Additional Orphan Designations Granted For Selinexor (KPT-330) By European Commission (EC)

  December 1, 2014

   · 

  5 min read
• Drug Development

  OncoMed Pharmaceuticals, Inc. Begins Patient Dosing In Phase 2 Clinical Trial of Tarextumab (Anti-Notch 2/3, OMP-59R5) in Small Cell Lung Cancer

  December 1, 2014

   · 

  9 min read
• Policy

  Momenta Pharmaceuticals, Inc. Announces Acceptance Of A Clinical Trial Application In Europe For M923, A Biosimilar Version Of Humira

  December 1, 2014

   · 

  4 min read
• Pluristem Therapeutics Granted Patent In Singapore For Its 3D Cell Expansion Technology

  December 1, 2014

   · 

  4 min read
• Business

  Affymax, Inc. Announces A Special Cash Distribution And The Appointment Of A New Director And Chief Executive Officer

  December 1, 2014

   · 

  3 min read
• Business

  Lombard Medical Technologies Appoints William J. Kullback As Chief Financial Officer

  December 1, 2014

   · 

  3 min read
• RedHill Biopharma Ltd. And IntelGenx Corp. Announce Acceptance For Review Of European Marketing Application For RIZAPORT For Migraines

  December 1, 2014

   · 

  8 min read
• Policy

  Baxter International, Inc. Submits Application For U.S. FDA Approval Of BAX 855, Extended Half-Life Recombinant FVIII Based On ADVATE For Hemophilia A

  December 1, 2014

   · 

  6 min read